Kan Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kan Liu has a total of 141 co-authors. Here are the top co-authors by number of shared publications:
- Jian Chen
Department of Cardiovascular Medicine, The Fifth Affiliated Hospital, Sun Yat-Sen University, Zhuhai, Guangdong 519000, China; Guangdong-Hong Kong-Macao University Joint Laboratory of Interventional Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai 519000, China
9 shared publications Amanda Chang
Department of Internal Medicine, University of Iowa, Iowa City, Iowa
7 shared publications- Xiaodong Wu
Department of Electrical and Computer Engineering, University of Iowa, Iowa City, Iowa, USA
7 shared publications Tou Kun Chong
Department of Cardiology, Kiang Wu Hospital, Macao, People's Republic of China
6 shared publicationsYi Grace Wang
Department of Mathematics, California State University Dominguez Hills , 1000 E. Victoria Street, Carson, CA 90747 , USA
5 shared publications- Amanda Chang
Department of Internal Medicine (A.C.), University of Iowa
4 shared publications
Latest Publications
- 11 November 2026
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
Motion-Informed Neural Network Towards Diastolic Mechanics in Takotsubo Syndrome
BACKGROUND: The pathophysiology of Takotsubo syndrome (TTS) remains perplexing. We developed a motion-informed neural network (MiNN-Echo) using echocardiograms to elucidate the diastolic mechanics of TTS. METHODS: We trained and validated MiNN-Echo, a deep convolutional neural network (2D+t) echocardiographic prediction model using multi-vendor echocardiograms from 1142 patients (596 TTS and 546 anterior myocardial infarction) in a multi-institutional cohort. A total of 68 expert echocardiographic readers performed human interpretation. The network’s dual-branch architecture independently learns spatial and temporal features, using 2-dimensional image frames for spatial representation and segmentation, and optical flow with sinusoidal phase encoding for temporal dynamics. The MiNN-Echo model integrates static cardiac anatomic changes with motion details from 2-dimensional echocardiographic videos to produce interpretable disease predictions. RESULTS: The MiNN-Echo model achieved an area under the curve of 0.77, compared with 0.69 among human readers in differentiating TTS from acute myocardial infarction. Myocardial motion features during diastole contributed more (≈71%) to the differential diagnosis than those during systole. Compared with patients with acute myocardial infarction, TTS patients showed increased isovolumic relaxation time (112.5 [interquartile range (IQR), 68.75–165.94] ms versus 87.5 [IQR, 54.17–140] ms, P P P P P =0.006), passive (0.45 [IQR, 0.33–0.58] versus 0.50 [IQR, 0.38–0.68]; P P =0.001) phases, and altered rotation angles (away from the horizontal A–V plane) in the passive ventricular filling phase (−70.19 [IQR, −89.62 to −41.33] versus −60.34 [IQR, −87.07 to −30.84]; P =0.020). CONCLUSIONS: MiNN-Echo in echocardiograms elucidates unique myocardial relaxation kinematics to characterize TTS-associated diastolic mechanics.
- 11 November 2026
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
Motion-Informed Neural Network Towards Diastolic Mechanics in Takotsubo Syndrome
BACKGROUND: The pathophysiology of Takotsubo syndrome (TTS) remains perplexing. We developed a motion-informed neural network (MiNN-Echo) using echocardiograms to elucidate the diastolic mechanics of TTS. METHODS: We trained and validated MiNN-Echo, a deep convolutional neural network (2D+t) echocardiographic prediction model using multi-vendor echocardiograms from 1142 patients (596 TTS and 546 anterior myocardial infarction) in a multi-institutional cohort. A total of 68 expert echocardiographic readers performed human interpretation. The network’s dual-branch architecture independently learns spatial and temporal features, using 2-dimensional image frames for spatial representation and segmentation, and optical flow with sinusoidal phase encoding for temporal dynamics. The MiNN-Echo model integrates static cardiac anatomic changes with motion details from 2-dimensional echocardiographic videos to produce interpretable disease predictions. RESULTS: The MiNN-Echo model achieved an area under the curve of 0.77, compared with 0.69 among human readers in differentiating TTS from acute myocardial infarction. Myocardial motion features during diastole contributed more (≈71%) to the differential diagnosis than those during systole. Compared with patients with acute myocardial infarction, TTS patients showed increased isovolumic relaxation time (112.5 [interquartile range (IQR), 68.75–165.94] ms versus 87.5 [IQR, 54.17–140] ms, P P P P P =0.006), passive (0.45 [IQR, 0.33–0.58] versus 0.50 [IQR, 0.38–0.68]; P P =0.001) phases, and altered rotation angles (away from the horizontal A–V plane) in the passive ventricular filling phase (−70.19 [IQR, −89.62 to −41.33] versus −60.34 [IQR, −87.07 to −30.84]; P =0.020). CONCLUSIONS: MiNN-Echo in echocardiograms elucidates unique myocardial relaxation kinematics to characterize TTS-associated diastolic mechanics.
- Open Access
- 28 July 2026
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 101 (11) , 2074-2076
Hemodynamic Vulnerability in Male Patients With Takotsubo Syndrome: Pathophysiologic Roles of Tachycardia
- 28 July 2026
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 101 (11) , 2074-2076
Open AccessHemodynamic Vulnerability in Male Patients With Takotsubo Syndrome: Pathophysiologic Roles of Tachycardia
- Open Access
- 27 April 2026
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 42 (9) , 1667-1674
The roles of quantitative doppler echocardiography in optimizing guideline-directed medical therapy in Post-STEMI patients
Patients with ST-segment elevation myocardial infarction (STEMI), who are at the highest risk, benefit the most from early guideline-directed medical therapy (GDMT). In real-world practice, timely application and titration of these medications are often compromised during the immediate post-STEMI period due to the perception of hemodynamic instability. An extended medication gap may last from the early post-STEMI period until outpatient follow-up weeks later, depriving prognostic benefit from key pharmacotherapy in the critical window of early post-infarct course. We discuss the practical hurdles in the post-STEMI period to commence GDMT, and the tactics to optimize risk management in high-risk patients to realize the benefits of GDMT. We highlight the challenges of real-time cardiac preload evaluation after coronary revascularization, and the emerging roles of quantitative Doppler echocardiography a point-of-care non-invasive imaging approaches in guiding preload titration to support early pharmacotherapy. We propose stepwise algorithms to integrate instantaneous quantitative Doppler assessment into routine post-STEMI management workflow, and outline our perspective for future trial design and clinical practice.
- 27 April 2026
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 42 (9) , 1667-1674
Open AccessThe roles of quantitative doppler echocardiography in optimizing guideline-directed medical therapy in Post-STEMI patients
Patients with ST-segment elevation myocardial infarction (STEMI), who are at the highest risk, benefit the most from early guideline-directed medical therapy (GDMT). In real-world practice, timely application and titration of these medications are often compromised during the immediate post-STEMI period due to the perception of hemodynamic instability. An extended medication gap may last from the early post-STEMI period until outpatient follow-up weeks later, depriving prognostic benefit from key pharmacotherapy in the critical window of early post-infarct course. We discuss the practical hurdles in the post-STEMI period to commence GDMT, and the tactics to optimize risk management in high-risk patients to realize the benefits of GDMT. We highlight the challenges of real-time cardiac preload evaluation after coronary revascularization, and the emerging roles of quantitative Doppler echocardiography a point-of-care non-invasive imaging approaches in guiding preload titration to support early pharmacotherapy. We propose stepwise algorithms to integrate instantaneous quantitative Doppler assessment into routine post-STEMI management workflow, and outline our perspective for future trial design and clinical practice.
- 11 April 2026
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 42 (11) , 2670
Machine Learning From Diastolic Function for Risk Prediction of Takotsubo Syndrome
- 11 April 2026
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 42 (11) , 2670
Machine Learning From Diastolic Function for Risk Prediction of Takotsubo Syndrome
- Open Access
- 26 March 2026
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 56 (4) , e70190
A nomogram for predicting in‐hospital death in a multinational cohort of patients with takotsubo syndrome
Background: An effective risk stratification model on hospitalized patients with takotsubo syndrome (TTS) helps guide treatment to mitigate adverse events and improve prognosis. We aimed to develop a nomogram for predicting in‐hospital death in a multinational cohort of TTS patients. Methods: We enrolled 829 TTS patients from AmSC Research Network, InterTAK registry and ChiTTS registry, classified into the training ( n = 578), test ( n = 145) and external validation ( n = 106) cohorts. Results: Body mass index (BMI), chronic kidney disease (CKD), neurologic disorders, cardiogenic shock, low systolic blood pressure (SBP, 9 /L) were independent positive predictors, while chest pain was an independent negative predictor of in‐hospital death. A nomogram was constructed to predict in‐hospital death in TTS patients based on these seven independent variables, which showed that the area under the curves (AUCs) in the training and test cohorts were .854 (95% CI: .805–.904, p < .001) and .836 (95% CI: .737–.934, p < .001), respectively. The calibration curves showed good consistency between the prediction of the nomogram and the actual observation in both the training and test cohorts. Decision curve analyses indicated that the use of the nomogram to predict in‐hospital death in TTS patients could provide better net benefit than the ‘treat all’ or ‘treat none’ strategies when the threshold probability ranged from 2% to 75% in the training cohort and from 2% to 72% in the test cohort. The nomogram was further validated, with AUC of .838 (95% CI: .663–1.000, p = .003) in the external validation cohort. Conclusions: The nomogram, composed of BMI, CKD, neurologic disorders, chest pain, cardiogenic shock, low SBP and abnormal WBC, helps predict in‐hospital death in TTS patients.
- 26 March 2026
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 56 (4) , e70190
Open AccessA nomogram for predicting in‐hospital death in a multinational cohort of patients with takotsubo syndrome
Background: An effective risk stratification model on hospitalized patients with takotsubo syndrome (TTS) helps guide treatment to mitigate adverse events and improve prognosis. We aimed to develop a nomogram for predicting in‐hospital death in a multinational cohort of TTS patients. Methods: We enrolled 829 TTS patients from AmSC Research Network, InterTAK registry and ChiTTS registry, classified into the training ( n = 578), test ( n = 145) and external validation ( n = 106) cohorts. Results: Body mass index (BMI), chronic kidney disease (CKD), neurologic disorders, cardiogenic shock, low systolic blood pressure (SBP, 9 /L) were independent positive predictors, while chest pain was an independent negative predictor of in‐hospital death. A nomogram was constructed to predict in‐hospital death in TTS patients based on these seven independent variables, which showed that the area under the curves (AUCs) in the training and test cohorts were .854 (95% CI: .805–.904, p < .001) and .836 (95% CI: .737–.934, p < .001), respectively. The calibration curves showed good consistency between the prediction of the nomogram and the actual observation in both the training and test cohorts. Decision curve analyses indicated that the use of the nomogram to predict in‐hospital death in TTS patients could provide better net benefit than the ‘treat all’ or ‘treat none’ strategies when the threshold probability ranged from 2% to 75% in the training cohort and from 2% to 72% in the test cohort. The nomogram was further validated, with AUC of .838 (95% CI: .663–1.000, p = .003) in the external validation cohort. Conclusions: The nomogram, composed of BMI, CKD, neurologic disorders, chest pain, cardiogenic shock, low SBP and abnormal WBC, helps predict in‐hospital death in TTS patients.
- Open Access
- 23 February 2026
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 42 (7) , 1520-1528
Integrating Imaging Markers for Clinical Risk Stratification of Takotsubo Syndrome
- 23 February 2026
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 42 (7) , 1520-1528
Open AccessIntegrating Imaging Markers for Clinical Risk Stratification of Takotsubo Syndrome
- Open Access
- 1 June 2025
- Published by AME Publishing Company in Cardiovascular Diagnosis and Therapy
- Vol. 15 (3) , 563-573
Comparison of clinical features and outcomes of Chinese patients with Takotsubo syndrome and acute myocardial infarction—results from the first Chinese Takotsubo syndrome registry
Background: Takotsubo syndrome (TTS) differs significantly from acute myocardial infarction (AMI) in clinical features and pathological mechanisms, but evidence in Asian populations remains limited. The aim of this study is to compare clinical features and outcomes between patients with TTS and AMI in the first Chinese registry of TTS (ChiTTS Registry, ChiCTR1900026725). Methods: In this multicenter 6-year retrospective cohort study (February 2016–June 2022), a total of 116 consecutive TTS patients diagnosed according to the international Takotsubo diagnostic criteria and 232 age- and sex-matched AMI patients (1:2 ratio) meeting the 2023 European Society of Cardiology guidelines criteria were enrolled from 10 tertiary medical centers across China. Clinical characteristics, in-hospital outcomes, and major adverse cardiovascular and cerebrovascular events (MACCEs) were compared between groups using Student’s t-test or Chi-squared test. Time-to-event analysis employed Kaplan-Meier/log-rank tests with landmark analysis. Results: The median follow-up time was 1.23 [interquartile range (IQR), 0.33–2.63] years in ChiTTS Registry patients and 2.35 (IQR, 1.68–3.68) years in AMI patients. In contrast to AMI patients, TTS patients presented with more clinical manifestations associated with acute heart failure. TTS patients developed approximately twice as many in-hospital complications as AMI patients (42.2% vs. 20.7%, Pvs. 10.8%, P=0.03) and all-cause mortality (17.9% vs. 8.9%, P=0.02). In comparison to AMI patients, the landmark analysis confirmed that TTS patients developed more 100-day MACCEs [hazard ratio (HR) 1.87; 95% confidence interval (CI): 1.03–3.37; log-rank test P=0.04] and all-cause mortality (HR 2.07; 95% CI: 1.10–3.91; log-rank test P=0.02). In contrast, no significant difference was found in long-term MACCEs (HR 0.38; 95% CI: 0.13–1.09; log-rank test P=0.06) and all-cause mortality (HR 0.96; 95% CI: 0.31–2.98; log-rank test P=0.94) between TTS and AMI patients. Conclusions: In comparison to AMI patients, Chinese TTS patients developed more in-hospital complications and had a worse short-term prognosis. The cardiovascular issues in TTS patients underscore the need for effective treatment and personalized strategies to enhance outcomes and mitigate risks.
- 1 June 2025
- Published by AME Publishing Company in Cardiovascular Diagnosis and Therapy
- Vol. 15 (3) , 563-573
Open AccessComparison of clinical features and outcomes of Chinese patients with Takotsubo syndrome and acute myocardial infarction—results from the first Chinese Takotsubo syndrome registry
Background: Takotsubo syndrome (TTS) differs significantly from acute myocardial infarction (AMI) in clinical features and pathological mechanisms, but evidence in Asian populations remains limited. The aim of this study is to compare clinical features and outcomes between patients with TTS and AMI in the first Chinese registry of TTS (ChiTTS Registry, ChiCTR1900026725). Methods: In this multicenter 6-year retrospective cohort study (February 2016–June 2022), a total of 116 consecutive TTS patients diagnosed according to the international Takotsubo diagnostic criteria and 232 age- and sex-matched AMI patients (1:2 ratio) meeting the 2023 European Society of Cardiology guidelines criteria were enrolled from 10 tertiary medical centers across China. Clinical characteristics, in-hospital outcomes, and major adverse cardiovascular and cerebrovascular events (MACCEs) were compared between groups using Student’s t-test or Chi-squared test. Time-to-event analysis employed Kaplan-Meier/log-rank tests with landmark analysis. Results: The median follow-up time was 1.23 [interquartile range (IQR), 0.33–2.63] years in ChiTTS Registry patients and 2.35 (IQR, 1.68–3.68) years in AMI patients. In contrast to AMI patients, TTS patients presented with more clinical manifestations associated with acute heart failure. TTS patients developed approximately twice as many in-hospital complications as AMI patients (42.2% vs. 20.7%, Pvs. 10.8%, P=0.03) and all-cause mortality (17.9% vs. 8.9%, P=0.02). In comparison to AMI patients, the landmark analysis confirmed that TTS patients developed more 100-day MACCEs [hazard ratio (HR) 1.87; 95% confidence interval (CI): 1.03–3.37; log-rank test P=0.04] and all-cause mortality (HR 2.07; 95% CI: 1.10–3.91; log-rank test P=0.02). In contrast, no significant difference was found in long-term MACCEs (HR 0.38; 95% CI: 0.13–1.09; log-rank test P=0.06) and all-cause mortality (HR 0.96; 95% CI: 0.31–2.98; log-rank test P=0.94) between TTS and AMI patients. Conclusions: In comparison to AMI patients, Chinese TTS patients developed more in-hospital complications and had a worse short-term prognosis. The cardiovascular issues in TTS patients underscore the need for effective treatment and personalized strategies to enhance outcomes and mitigate risks.
- Open Access
- 8 May 2025
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 26 (5) , 28173
Tricuspid Regurgitation: A Comprehensive Review of Clinical, Imaging and Therapy
Once considered the “forgotten valve and ventricle”, the tricuspid valve and right ventricle are now recognized as critical structures with significant clinical and prognostic implications. Growing evidence has highlighted that tricuspid regurgitation (TR) and right heart failure are not merely secondary phenomena that resolve following the treatment of left-sided heart disease. Instead, TR and right heart failure contribute to adverse outcomes and increased mortality if left untreated. This paradigm shift has fueled extensive clinical research, leading to a deeper understanding of the pathophysiology of TR and right ventricular (RV) dysfunction. Additionally, advancements in cardiovascular imaging have facilitated early detection, risk stratification, and innovative therapeutic approaches for TR and right heart failure. This article explores the evolving landscape of tricuspid valve disease, emphasizing the importance of early recognition and the role of emerging imaging technologies in improving patient outcomes. Thanks to progress in imaging technology, especially echocardiography, as well as cardiac magnetic resonance and cardiac computer tomography, enhanced studies can be conducted on the tricuspid valve pathology to delineate the various mechanisms involved in TR and RV dysfunction and offer patients a tailored medical, as well as surgical and transcatheter therapies. These unparalleled technological advances would not be possible without the hard work of physicians, scientists, surgeons, interventional cardiologists, and echocardiographers worldwide, despite the many challenges they experience daily and in every procedure. Many patients with TR present at an advanced stage of disease progression, often with severe regurgitation and clinical manifestations associated with poor outcomes. Additionally, a significant proportion of these patients have either undergone previous open-heart surgery for left-sided valvular disease or are considered high-risk surgical candidates due to multiple comorbid conditions. In recent years, transcatheter therapy has emerged as a viable alternative for this high-risk population, offering a less invasive option for those previously deemed “inoperable”. This breakthrough has transformed the therapeutic landscape for valvular heart disease, particularly for TR, providing new hope and improved outcomes for patients who were once left with limited treatment options.
- 8 May 2025
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 26 (5) , 28173
Open AccessTricuspid Regurgitation: A Comprehensive Review of Clinical, Imaging and Therapy
Once considered the “forgotten valve and ventricle”, the tricuspid valve and right ventricle are now recognized as critical structures with significant clinical and prognostic implications. Growing evidence has highlighted that tricuspid regurgitation (TR) and right heart failure are not merely secondary phenomena that resolve following the treatment of left-sided heart disease. Instead, TR and right heart failure contribute to adverse outcomes and increased mortality if left untreated. This paradigm shift has fueled extensive clinical research, leading to a deeper understanding of the pathophysiology of TR and right ventricular (RV) dysfunction. Additionally, advancements in cardiovascular imaging have facilitated early detection, risk stratification, and innovative therapeutic approaches for TR and right heart failure. This article explores the evolving landscape of tricuspid valve disease, emphasizing the importance of early recognition and the role of emerging imaging technologies in improving patient outcomes. Thanks to progress in imaging technology, especially echocardiography, as well as cardiac magnetic resonance and cardiac computer tomography, enhanced studies can be conducted on the tricuspid valve pathology to delineate the various mechanisms involved in TR and RV dysfunction and offer patients a tailored medical, as well as surgical and transcatheter therapies. These unparalleled technological advances would not be possible without the hard work of physicians, scientists, surgeons, interventional cardiologists, and echocardiographers worldwide, despite the many challenges they experience daily and in every procedure. Many patients with TR present at an advanced stage of disease progression, often with severe regurgitation and clinical manifestations associated with poor outcomes. Additionally, a significant proportion of these patients have either undergone previous open-heart surgery for left-sided valvular disease or are considered high-risk surgical candidates due to multiple comorbid conditions. In recent years, transcatheter therapy has emerged as a viable alternative for this high-risk population, offering a less invasive option for those previously deemed “inoperable”. This breakthrough has transformed the therapeutic landscape for valvular heart disease, particularly for TR, providing new hope and improved outcomes for patients who were once left with limited treatment options.
- Open Access
- 1 July 2024
- Published by Wolters Kluwer Health in Cardiology Plus
- Vol. 9 (3) , 187-194
Epidemiology, diagnosis, and treatment of Takotsubo syndrome: a comprehensive review
Takotsubo syndrome (TTS) is characterized by apical or left ventricular (LV) ballooning and impaired wall motion as its primary features. Although women over 55 years make up the majority of TTS patients, male patients have a greater incidence of in-hospital mortality. TTS also impacts pregnant women and children, with conflicting information regarding racial differences. TTS has an in-hospital mortality rate comparable to that of acute ST-segment elevation myocardial infarction, and higher than that in patients with myocarditis. More than 10% of patients may experience a subsequent acute episode within 5 years after the initial event. TTS exhibits symptoms such as chest pain, electrocardiograph (ECG) abnormalities, elevated B-type natriuretic peptide (BNP), and N-terminal prohormone of brain natriuretic peptide (NT-pro-BNP) levels, and changes in several imaging approaches, which may aid in early diagnosis. Fluid resuscitation, β-blockers, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), anti-anxiety or depression drugs, and cardiac rehabilitation may be employed to treat TTS, reduce recurrence rates, and improve functional exercise capacity and exercise time. After searching PubMed, Research Gate, Science Direct, and Web of Science, we summarized recent researches on epidemiology, diagnosis, treatments, and prognosis. These findings provide a theoretical basis for future clinical practice and will aid doctors and researchers investigating the unknown aspects of TTS.
- 1 July 2024
- Published by Wolters Kluwer Health in Cardiology Plus
- Vol. 9 (3) , 187-194
Open AccessEpidemiology, diagnosis, and treatment of Takotsubo syndrome: a comprehensive review
Takotsubo syndrome (TTS) is characterized by apical or left ventricular (LV) ballooning and impaired wall motion as its primary features. Although women over 55 years make up the majority of TTS patients, male patients have a greater incidence of in-hospital mortality. TTS also impacts pregnant women and children, with conflicting information regarding racial differences. TTS has an in-hospital mortality rate comparable to that of acute ST-segment elevation myocardial infarction, and higher than that in patients with myocarditis. More than 10% of patients may experience a subsequent acute episode within 5 years after the initial event. TTS exhibits symptoms such as chest pain, electrocardiograph (ECG) abnormalities, elevated B-type natriuretic peptide (BNP), and N-terminal prohormone of brain natriuretic peptide (NT-pro-BNP) levels, and changes in several imaging approaches, which may aid in early diagnosis. Fluid resuscitation, β-blockers, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), anti-anxiety or depression drugs, and cardiac rehabilitation may be employed to treat TTS, reduce recurrence rates, and improve functional exercise capacity and exercise time. After searching PubMed, Research Gate, Science Direct, and Web of Science, we summarized recent researches on epidemiology, diagnosis, treatments, and prognosis. These findings provide a theoretical basis for future clinical practice and will aid doctors and researchers investigating the unknown aspects of TTS.